Results 11 to 20 of about 1,561 (140)

Trastuzumab Deruxtecan‐Induced Myotoxicity: First Case Report About Myopathy in Patient With Normal Body Composition and Clinical Insights [PDF]

Thoracic Cancer
Trastuzumab deruxtecan (T‐DXd) significantly improves outcomes in HER2‐positive or low metastatic breast cancer (MBC), but systematic documentation of its myotoxicity is lacking. A 45‐year‐old woman with HER2‐low MBC and normal body composition (BMI 22.9 
Zhen Qiao, LiuDan Li, Hong Wang, ShuHui Dai, LiTong Ye   +4 more
doaj   +3 more sources

Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy [PDF]

Translational Oncology
Summary: Acidic tumor microenvironments promote malignant progression, immune evasion, and drug resistance. This single-center retrospective cohort study evaluated whether, among patients with stage IV non-small cell lung cancer (NSCLC) who participated ...
Shion Kachi, Kazuyuki Suzuki, Reo Hamaguchi, Ryoko Narui, Hiromasa Morikawa, Hiromi Wada   +5 more
doaj   +2 more sources

Effects of Citrate Mixture on Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Underexcretion-Type Gout Patients: A Prospective Cohort Study [PDF]

Journal of Inflammation Research
Lingfang Xu,1,* Jidong Cheng,2,* Lingling Cui,1,* Kai Guo,1 Can Wang,1 Han Qi,2 Qian Zhang,2 Yuwei He,1 Xinde Li,1 Lin Han,1 Xuefeng Wang,1 Wenyan Sun,1 Xueyan Zhang,3 Mingshu Sun,4 Changgui Li,1,2,* Zhen Liu1,&ast ...
Xu L, Cheng J, Cui L, Guo K, Wang C, Qi H, Zhang Q, He Y, Li X, Han L, Wang X, Sun W, Zhang X, Sun M, Li C, Liu Z   +15 more
doaj   +2 more sources

Meaning and Significance of “Alkalization Therapy for Cancer”

Frontiers in Oncology, 2022
Objectives of the StudyOur research aims to answer the following questions. Can cancer progression be stopped by changing the body condition of person with cancer? Can cancer be cured?If cancer progression can be stopped, what is the underlying mechanism?
Reo Hamaguchi, Hiromasa Morikawa, Ryoko Narui   +2 more
exaly   +3 more sources

Unusual case of Myroides odoratimimus infection in a cancer patient: addressing its antimicrobial resistance mechanisms and review of the literature [PDF]

Frontiers in Cellular and Infection Microbiology
IntroductionMyroides odoratimimus is a Gram-negative opportunistic pathogen primarily affecting immunocompromised individuals. However, its resistance characteristics and therapeutic response in cancer patients remain poorly defined.
Lingying Fan, Yiping Chen
doaj   +2 more sources

Lazertinib‐Induced Rhabdomyolysis in a Patient With Non‐Small Cell Lung Cancer: A Case Report [PDF]

Respirology Case Reports
Lazertinib is a third‐generation epidermal growth factor receptor tyrosine kinase inhibitor effective in patients with non‐small cell lung cancer. Although generally well tolerated, this case report presents a rare occurrence of common terminology ...
Seunghun Lee, Juwhan Choi, Sung Yong Lee
doaj   +2 more sources

Simultaneous inactivation of antibiotic-resistant bacteria and degradation of antibiotic-resistant genes in alkalised human urine. [PDF]

Front Microbiol
The coexistence of pharmaceuticals and microorganisms in source separated urine poses a risk for the development of antimicrobial resistance (AMR), especially when urine-based fertilizers are applied to soils. While prior studies have investigated pathogen inactivation in source-separated wastewater matrices, few have evaluated the simultaneous fate of
Demissie N, Nordin A, Simha P, Conroy I, Sun H, Schnürer A, Vinnerås B, Desta A.   +7 more
europepmc   +5 more sources

Urinary tract infection with Torulopsis glabrata treated by alkalization of urine. [PDF]

BMJ: British Medical Journal, 1965
L, Edebo, A, Spetz
exaly   +3 more sources

Serum Methotrexate Level Predicts Acute Kidney Injury After High-Dose Methotrexate: A Case Report and Single-Center Experience [PDF]

International Journal of Nephrology and Renovascular Disease
Pao-Wen Yen,1 Hsing-Yu Lin,2 Chien-Chih Wu,2 Tai-Chung Huang,3 Shang-Ju Wu,3 Szu-Yu Pan,1,4 Kuan-Yu Hung1,5 1Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; 2Department of Pharmacy ...
Yen PW, Lin HY, Wu CC, Huang TC, Wu SJ, Pan SY, Hung KY   +6 more
doaj   +2 more sources

A Rare Case of Concurrent Urinothorax and Myelomatous Pleural Effusion. [PDF]

Case Rep Pulmonol
Introduction Myelomatous pleural effusion (MPE) is a rare complication of multiple myeloma, occurring in < 1% of cases and associated with poor prognosis. Urinothorax, another rare cause of pleural effusion, results from urine leakage into the pleural cavity, typically due to obstructive uropathy or trauma.
Bhanvadia P, Lalani A, Samadami S, Bawa A, Wagle L.   +4 more
europepmc   +2 more sources